JERUSALEM--(BUSINESS WIRE)--Dec. 6, 2012--
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) invites investors and
the general public to listen to a live audio webcast of its 2012
Investor Meeting on Tuesday, December 11, 2012 at 12:00 p.m. ET.
|
|
|
|
|
|
What:
|
|
|
Teva’s 2012 Investor Meeting
|
|
|
|
|
|
|
Who:
|
|
|
Teva Management
|
|
|
|
|
|
|
When:
|
|
|
Tuesday, December 11, 2012 at 12:00 p.m. ET
|
|
|
|
|
|
|
Where:
|
|
|
www.tevapharm.com
|
|
|
|
|
|
|
How:
|
|
|
Live over the Internet -- log on to the Web at the address above and
register for the event (approx. 10 minutes before). An archive of
the webcast will be available on Teva's website.
|
|
|
|
|
|
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
leading generic drug maker, with a global product portfolio of more than
1,300 molecules and a direct presence in about 60 countries. Teva's
branded businesses focus on CNS, oncology, pain, respiratory and women's
health therapeutic areas as well as biologics. Teva currently employs
approximately 46,000 people around the world and reached $18.3 billion
in net revenues in 2011.
Source: Teva Pharmaceutical Industries Ltd.
IR:
Kevin C. Mannix
United States
215-591-8912
Joseph
Marczely
United States
267-468-4281
Tomer Amitai
Israel
972
(3) 926-7656
or
PR:
Hadar Vismunski-Weinberg
Israel
972
(3) 926-7687
Denise Bradley
United States
215-591-8974